Where does Oceans Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Oceans Co., Ltd. ranks #36,778 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Oceans Co., Ltd. hold?

Oceans Co., Ltd. holds 7 US utility patents granted between 2018 and 2022, spanning 11 technology areas.

What is Oceans Co., Ltd.'s Innovation Score?

Oceans Co., Ltd. has an Innovation Score of 30.2 out of 100 (33rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Oceans Co., Ltd. focus on?

Oceans Co., Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents, ranking #3,434 of 6,058 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Oceans Co., Ltd.'s patent grant rate increasing or decreasing?

Oceans Co., Ltd.'s recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Oceans Co., Ltd.'s patents?

Oceans Co., Ltd.'s patents average 11.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Oceans Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Oceans Co., Ltd.

USPTO PatentsView assignee record - 7 granted patents across 11 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Oceans ranks #36,778 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 11 technology areas.

#36,778
of 49,997 US assignees by volume: 33rd percentile
by Innovation Score (30.2/100): 11.4
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36778 · Foreign Corporation #36,778 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #36,778/49,997
PHOTO-FINISH Oblique Therapeutics…
CPC-FOCUS A61P · 11 areas
INNOV-THIN 30.2/100
CLAIMS-PAR 11.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Oblique Therapeutics AB (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Oceans’s 30.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (24%) Velocity 4.4 pts (15%) Breadth 11.7 pts (39%) Claim depth 6.9 pts (23%)

Qualcomm Incorporated · highest

85
Oceans · this assignee

30
3D Lighting… · lowest

7

What this shows Oceans's Innovation Score is 30.2/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Oceans?

Each dot is one of Oceans’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Oceans’s own 11.4 claims/patent is at or below the 14.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Oceans vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Oceans's grants concentrate

Oceans Co., Ltd. is a focused PatentsView assignee: 11 CPC subclasses with 71.4% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2020. By volume, Oceans sits between Oblique Therapeutics AB and Olatec Industries LLC.

Oceans's three-year grant acceleration

Oceans Co., Ltd. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Oblique Therapeut…

7
Observatoire DE P…

7
Obsidian Therapeu…

7
Oceana Energy

7
Ofip

7
Oishi Koseido

7
Oita University

7
Olatec Industries

7
Oceans ◀

7

What this shows Oceans holds 7 patents at rank #36,757, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Oceans

By rank, the assignees closest to #36,757 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Oceans's primary technology class.

Oceans's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Oceans Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	28.6%
2019	2	28.6%
2020	1	14.3%
2022	2	28.6%

Which technologies does Oceans Co., Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 2

B63B - Ships OR Other Waterborne VESSELS; Equipment FOR Shipping 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C07C - Acyclic OR Carbocyclic Compounds 1

H04N - Pictorial Communication, e.g. Television 1

G06T - Image Data Processing OR Generation, IN General 1

B43L - Articles FOR Writing OR Drawing UPON; ; Writing OR Drawing AIDS;; Accessories FOR Writing OR Drawing 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

C07D - Heterocyclic Compounds 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Oceans Co., Ltd.'s patent record in context - here's where to go next.

Oceans Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 71.4% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #36,778 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Oceans Co., Ltd. against Oblique Therapeutics AB, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.